lomerizine has been researched along with Ischemic Attack, Transient in 4 studies
lomerizine: used to treat migraines
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, A | 1 |
| Ozaki, A | 1 |
| Ikegami, A | 1 |
| Hayashi, A | 1 |
| Hara, H | 2 |
| Sukamoto, T | 2 |
| Ito, K | 1 |
| Harada, K | 2 |
| Handa, J | 2 |
| Shiino, A | 1 |
| Kidooka, M | 1 |
| Nakasu, Y | 1 |
| Matsuda, M | 1 |
1 review available for lomerizine and Ischemic Attack, Transient
| Article | Year |
|---|---|
[Ca antagonists in neurosurgical practice].
Topics: Animals; Anticonvulsants; Brain; Calcium Channel Blockers; Cerebral Infarction; Disease Models, Anim | 1990 |
3 other studies available for lomerizine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Effects of a new diphenylpiperazine calcium antagonist, KB-2796, on cerebral ischemic neuronal damage in rats.
Topics: Animals; Brain; Calcium Channel Blockers; Energy Metabolism; Glucose; Ischemic Attack, Transient; Ma | 1993 |
Chronological atrophy after transient middle cerebral artery occlusion in rats.
Topics: Animals; Atrophy; Brain; Calcium Channel Blockers; Cerebral Arteries; Excitatory Amino Acid Antagoni | 1993 |
Effects of a new Ca2+ antagonist, KB-2796, on the regional cerebral blood flow and somatosensory evoked potentials in the ischemic brain in cats.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Cats; Cerebrovascular Circulation; Drug Evaluatio | 1988 |